2017-02-14 / Admin / 72
Bipolar Disorder Candidate Gene, Validated in Mouse Experiment

Bipolar Disorder Candidate Gene, Validated in Mouse Experiment

Their findings published in the recent issue of the journal Molecular Psychiatry.

A team of researchers, affiliated with UNIST has made a significant breakthrough in the search for the potential root causes of bipolar disorder.

The research team, led by Professor Pan-gil Suh of Life Sciences at UNIST conducted a study that suggests the cellular protein Phospholipase Cγ1 (PLCγ1) could be a new promising candidate gene for bipolar disorder, also known as manic-depressive illness.

The research published by the journal Molecular Psychiatry outlines the findings on January 31, 2017. The findings provide evidence that PLCγ1 is critical for synaptic function and plasticity and that the loss of PLCγ1 from the forebrain results in manic-like behavior. This breakthrough is expected to be widely used in research for the treatment ofthe manic symptoms associated with bipolar disorder.

The PLCγ1 protein has once been proposed as a candidate risk indicator for bipolar disorder in previous studies. However, it has been unclear that how the PLCγ1 protein plays a role in neron-to-neuron signalling and how it is related to mental illnesses, like bipolar disorder.

In the study, Professor Suh and his team created a mouse with PLCγ1 removed from the front lobe and observed what happened in the brain synapse of this mouse. Synapse is the part of the neuron (neuron) where the signal is transmitted from the end.

To test whether dysfunction of PLCγ1 in the brain contributes to hyperactive behavior, the research team generated mouse models, lacking PLCγ1 in the forebrain and studied the synaptic and neuronal changes in mouse models.

The research team reported that mice with forebrain-selective deletion of PLCγ1 also exhibit mani-like behaviour, as well as deficits in inhibitory transmission and BDNF-dependent synaptic plasticity.

This resulted in the the imbalance between excitatory and inhibitory inputs in forebrain circuits, leading to behavioral abnormalities and manic episodes of bipolar disorder. These symptoms were alleviated after the treatment for bipolar disorder was given.

“In the brain, excitatory synapses and inhibitory synapses work together to remain balanced for proper neurotransmission,” says Professor Suh. “Our study demonstrated that the imbalance between these two is a major cause of various neuropsychiatric disorders and the GABAergic dysfunction observed in the hippocampi of bipolar disorder patients.”

According to the research team, the inhibitory synapses that lacks PLCγ1 protein do not work properly in excitatory neurons. This is due to the improper signaling of BDNF, which is critical for the synapse formation. This leads to an imbalance of excitatory synapses and inhibitory synapses, and causes mental illnesses, like bipolar disorder.

“After 10 years of research, we have finally revealed PLCγ1 protein plays a major role in the onset of bipolar disorder,” says Professor Suh. “Our findings, therefore, provide evidence that PLCγ1 is critical for synaptic function and plasticity and that the loss of PLCγ1 from the forebrain results in manic-like behavior.”

The research was carried out with the support of the future creation science department and the Korea Research Foundation.

https://youtu.be/zKGPSzvLtCs

Journal Reference
Y R Yang, et al.,”Forebrain-specific ablation of phospholipase Cγ1 causes manic-like behavior,” Molecular Psychiatry, (2017).